Global Ultrasound Elastography System Market Size, Share, Analysis Report - Forecast 2032

Ultrasound Elastography System Market Insights

According to Market Research Store, the global ultrasound elastography system market size was valued at around USD 5.07 billion in 2023 and is estimated to reach USD 9.64 billion by 2032, to register a CAGR of approximately 7.4% in terms of revenue during the forecast period 2024-2032.

The ultrasound elastography system report provides a comprehensive analysis of the market, including its size, share, growth trends, revenue details, and other crucial information regarding the target market. It also covers the drivers, restraints, opportunities, and challenges till 2032.

To Get more Insights, Request a Free Sample

Global Ultrasound Elastography System Market: Overview

Ultrasound elastography system is a medical imaging technology that combines traditional ultrasound with elastography, a technique used to assess the stiffness or elasticity of tissues. This system helps clinicians evaluate the mechanical properties of tissues in real-time, which is crucial for diagnosing and monitoring various conditions, particularly in the liver, musculoskeletal system, and soft tissues. The system works by sending sound waves into the tissue and measuring how the tissue deforms in response to these waves. The degree of tissue stiffness or elasticity is then quantified, which can help detect abnormalities such as tumors, fibrosis, and other pathologies that may alter tissue consistency.

The growth of the ultrasound elastography market is being driven by factors like the increasing prevalence of chronic diseases (such as liver disease and cancer), advancements in elastography technology that enhance the accuracy and resolution of measurements, and the rising demand for non-invasive diagnostic tools. Additionally, the integration of elastography into portable and compact ultrasound devices is making it more accessible, especially in outpatient settings and rural areas. The market is also benefiting from the development of elastography systems that offer improved image quality, faster processing times, and greater user-friendliness, further accelerating their adoption across medical specialties.

Key Highlights

• The ultrasound elastography system market is anticipated to grow at a CAGR of 7.4% during the forecast period.
• The global ultrasound elastography system market was estimated to be worth approximately USD 5.07 billion in 2023 and is projected to reach a value of USD 9.64 billion by 2032.
• The growth of the ultrasound elastography system market is being driven by the increasing demand for non-invasive diagnostic techniques.
• Based on the technique, the static elastography segment is growing at a high rate and is projected to dominate the market.
• On the basis of application, the liver disease segment is projected to swipe the largest market share.
• In terms of end-user, the hospitals segment is expected to dominate the market.
• By region, North America is expected to dominate the global market during the forecast period.

Ultrasound Elastography System Market: Dynamics

Key Growth Drivers:

• Rising Prevalence of Chronic Liver Diseases: The increasing incidence of non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and hepatitis B and C, which can lead to liver fibrosis and cirrhosis, is a major driver for the adoption of ultrasound elastography for non-invasive liver stiffness assessment.
• Growing Applications in Breast Cancer Diagnosis: Elastography can help differentiate benign from malignant breast lesions, reducing the need for invasive biopsies. The rising incidence of breast cancer and the focus on early detection contribute to market growth.
• Increasing Use in Thyroid Nodule Evaluation: Elastography aids in assessing the risk of malignancy in thyroid nodules, potentially decreasing the number of unnecessary fine-needle aspirations (FNAs).
• Expanding Applications in Musculoskeletal Imaging: Elastography is increasingly used to evaluate tendon and muscle stiffness, aiding in the diagnosis and management of musculoskeletal disorders and sports injuries.
• Demand for Non-Invasive Diagnostic Procedures: Patients and clinicians prefer non-invasive diagnostic methods over invasive procedures like biopsies due to reduced discomfort, lower risk of complications, and faster turnaround times, driving the adoption of ultrasound elastography.
• Technological Advancements in Ultrasound Elastography: Continuous innovations in elastography techniques, such as shear wave elastography (SWE) and strain elastography, leading to improved accuracy, reproducibility, and ease of use, are fueling market growth.

Restraints:

• High Cost of Advanced Elastography Systems: High-end ultrasound systems with advanced elastography capabilities can be expensive, posing a financial barrier for smaller hospitals and clinics, especially in developing regions.
• Technical Complexity and Need for Trained Sonographers: Performing and interpreting elastography examinations requires specific training and expertise. A shortage of adequately trained sonographers can limit the widespread adoption of the technology.
• Variability in Results and Operator Dependence: Strain elastography, in particular, can be subjective and operator-dependent, leading to variability in results. Efforts to standardize techniques and reduce operator dependence are ongoing.
• Limited Reimbursement in Some Regions: In certain healthcare systems, the reimbursement for ultrasound elastography procedures may be limited or inconsistent, hindering its adoption.
• Lack of Robust Long-Term Clinical Outcome Data: While elastography has shown promise in various applications, more extensive long-term clinical outcome data is needed to solidify its role in diagnostic pathways and treatment monitoring.
• Artifacts and Technical Challenges in Certain Patient Populations: Factors such as patient body habitus, presence of ascites, or superficial lesion location can sometimes lead to artifacts and technical challenges in obtaining reliable elastography measurements.

Opportunities:

• Development of More Affordable and Portable Systems: The introduction of more cost-effective and portable ultrasound systems with elastography capabilities can expand access to smaller clinics and point-of-care settings.
• Integration of Artificial Intelligence (AI) for Image Analysis: AI algorithms can assist in image analysis, reduce operator variability, and potentially improve the accuracy and efficiency of elastography interpretation.
• Expansion of Clinical Applications: Ongoing research is exploring the potential of ultrasound elastography in new clinical areas, such as kidney disease, prostate cancer, and cardiovascular applications, which could significantly expand the market.
• Development of Standardized Protocols and Guidelines: Efforts to establish standardized protocols and clinical guidelines for elastography procedures can improve consistency and facilitate wider adoption.
• Increased Training and Education Programs: Expanding training programs for sonographers and radiologists on the proper techniques and interpretation of ultrasound elastography will be crucial for its successful implementation.
• Growing Awareness and Acceptance Among Clinicians: As more evidence emerges supporting the clinical utility of ultrasound elastography, its awareness and acceptance among a broader range of clinicians are expected to increase.

Challenges:

• Improving Accuracy and Reproducibility Across Different Systems and Operators: Ensuring consistent and reliable elastography measurements across various ultrasound systems and different operators remains a key challenge.
• Establishing Clear Diagnostic Cut-off Values for Different Diseases: Determining standardized and validated cut-off values for tissue stiffness in various diseases is crucial for clinical decision-making but requires further research.
• Differentiating Between Inflammation and Fibrosis: Elastography primarily measures tissue stiffness, and distinguishing between stiffness caused by inflammation versus fibrosis can be challenging in some clinical scenarios.
• Validating Elastography Findings Against Histopathology: While aiming to reduce biopsies, validating elastography findings against the gold standard of histopathology is essential for establishing its accuracy and clinical utility.
• Keeping Pace with Rapid Technological Advancements: The field of ultrasound technology is constantly evolving, requiring ongoing research and development to integrate the latest advancements into elastography systems.
• Demonstrating Clear Clinical Utility and Cost-Effectiveness: Convincing healthcare providers and payers of the clear clinical benefits and cost-effectiveness of ultrasound elastography compared to traditional diagnostic methods is crucial for its widespread adoption.

Ultrasound Elastography System Market: Report Scope

This report thoroughly analyzes the Ultrasound Elastography System Market, exploring its historical trends, current state, and future projections. The market estimates presented result from a robust research methodology, incorporating primary research, secondary sources, and expert opinions. These estimates are influenced by the prevailing market dynamics as well as key economic, social, and political factors. Furthermore, the report considers the impact of regulations, government expenditures, and advancements in research and development on the market. Both positive and negative shifts are evaluated to ensure a comprehensive and accurate market outlook.

Ultrasound Elastography System Market: Segmentation Insights

The global ultrasound elastography system market is divided by technique, application, end-user, and region.

Segmentation Insights by Technique

Based on technique, the global ultrasound elastography system market is divided into static elastography, dynamic elastography with harmonic stimuli, and dynamic elastography with transient stimuli.

Static Elastography is the dominant technique in the Ultrasound Elastography System Market, as it is widely used for assessing tissue stiffness in clinical practice. Static elastography involves applying a compressive force to the tissue and measuring the resulting deformation. It is particularly useful for detecting fibrosis or liver diseases, as well as for evaluating other conditions such as breast cancer or thyroid lesions. The simplicity, cost-effectiveness, and reliability of static elastography make it a preferred choice for many healthcare facilities, leading to its high demand in both diagnostic and clinical settings.

Dynamic Elastography with Harmonic Stimuli is another key technique in the market, used to measure tissue stiffness in real-time while applying specific harmonic vibrations to the tissue. This method is beneficial for more accurate and precise measurements, particularly in the evaluation of soft tissues and the assessment of more subtle changes in stiffness. Dynamic elastography with harmonic stimuli is gaining traction in research and advanced diagnostic applications, especially for conditions that require detailed tissue characterization, such as liver fibrosis or muscle disorders. The growing demand for enhanced imaging techniques to provide better diagnostic accuracy is driving the adoption of this technology.

Dynamic Elastography with Transient Stimuli utilizes quick, transient forces to assess tissue stiffness and elasticity. This technique is particularly useful for evaluating lesions and tumors, providing real-time data on the mechanical properties of tissues under stress. The transient stimuli help in assessing the tissue response to rapid deformation, which can provide insights into the structure and health of the tissue. As this technology improves and more advanced ultrasound elastography systems are developed, it is becoming increasingly important in both clinical and research settings, offering potential for broader applications, particularly in oncology and musculoskeletal diseases.

Segmentation Insights by Application

On the basis of application, the global ultrasound elastography system market is bifurcated into liver disease, breast lesion, prostate cancer, thyroid, kidney, lymph node, and others.

Liver Disease is the dominant application in the Ultrasound Elastography System Market. The technology is widely used for assessing liver stiffness, which is an important indicator of liver diseases such as fibrosis, cirrhosis, and non-alcoholic fatty liver disease (NAFLD). Ultrasound elastography provides a non-invasive method for evaluating the extent of liver damage and monitoring disease progression or response to treatment. Its ability to replace traditional invasive biopsy procedures makes it highly popular in clinical practice, leading to its high demand in liver disease applications.

Breast Lesion is another significant application of ultrasound elastography, particularly in the detection and characterization of breast tumors. Elastography helps distinguish between benign and malignant lesions based on tissue stiffness, providing valuable diagnostic information to clinicians. This application is growing due to the increasing focus on non-invasive diagnostic tools for breast cancer detection and monitoring. The rise in breast cancer awareness and early detection initiatives is further contributing to the demand for elastography in this field.

Prostate Cancer is also an important application of ultrasound elastography, as the technology is used to assess the stiffness of prostate tissue, which can be indicative of malignancy. Elastography is used in combination with other imaging techniques like transrectal ultrasound (TRUS) to improve the accuracy of prostate cancer diagnosis. The adoption of elastography for prostate cancer is growing as it offers a non-invasive, real-time method for assessing tumor stiffness and guiding biopsy procedures, contributing to its increased use in urology.

Thyroid applications also make up a key segment of the market, with ultrasound elastography being used to assess the stiffness of thyroid nodules. This is particularly useful in determining whether a nodule is benign or malignant, thereby helping in the management of thyroid conditions. The growing prevalence of thyroid disorders, coupled with the need for accurate and non-invasive diagnostic methods, has contributed to the increased use of elastography for thyroid evaluation.

Kidney applications are expanding as ultrasound elastography is increasingly being used to assess kidney stiffness in conditions such as chronic kidney disease (CKD). Monitoring kidney stiffness can provide insights into the severity of CKD and other renal conditions, which is crucial for early diagnosis and treatment planning. As the global burden of kidney diseases rises, elastography is expected to play a more prominent role in kidney diagnostics.

Lymph Node applications involve using ultrasound elastography to assess the stiffness of lymph nodes, which can help in the detection of metastasis and the staging of cancers, particularly lymphoma and metastatic tumors. Elastography is used as a supplementary tool to traditional ultrasound imaging, offering better sensitivity in identifying malignant nodes. This application is growing as elastography becomes more refined and widely adopted in oncology practices.

Segmentation Insights by End-User

On the basis of end-user, the global ultrasound elastography system market is bifurcated into hospitals, diagnostic imaging centers, and radiology centers.

Hospitals are the dominant end-user in the Ultrasound Elastography System Market, as they are the primary healthcare facilities where a wide range of diagnostic and therapeutic procedures are carried out. Hospitals are increasingly adopting elastography systems due to their non-invasive nature, providing real-time imaging and reducing the need for more invasive procedures like biopsies. The growing focus on early disease detection, particularly in liver, breast, and prostate cancers, as well as liver diseases, is driving the demand for elastography systems in hospitals. Hospitals also benefit from elastography's ability to streamline patient care, offering faster diagnosis and improved treatment planning.

Diagnostic Imaging Centers are another important end-user segment, as they specialize in providing advanced imaging services, including ultrasound elastography. These centers offer diagnostic imaging for various medical conditions, and elastography is becoming an integral part of their offerings. The demand for elastography in diagnostic imaging centers is driven by the growing need for non-invasive diagnostic techniques for tissue stiffness evaluation, which is critical in detecting and monitoring diseases such as liver fibrosis, cancer, and thyroid disorders. As these centers cater to patients requiring specific diagnostic services, they are expected to see continued growth in elastography adoption.

Radiology Centers represent a significant end-user market, as elastography is increasingly integrated into radiology practices for comprehensive diagnostic services. Radiology centers use elastography alongside other imaging modalities to evaluate tissue stiffness, particularly in oncology and musculoskeletal diseases. The increasing use of elastography for cancer detection, liver disease diagnosis, and other conditions is making it an essential tool in the radiology space. As healthcare providers seek more advanced, efficient, and non-invasive diagnostic solutions, radiology centers are likely to see continued growth in the use of ultrasound elastography systems.

Ultrasound Elastography System Market: Regional Insights

• North America is expected to dominate the global market.

North America dominates the Ultrasound Elastography System Market, particularly due to the advanced healthcare infrastructure and a high rate of adoption of cutting-edge medical technologies in the United States and Canada. The market is driven by the increasing demand for non-invasive diagnostic methods for assessing tissue stiffness, which is essential in diagnosing liver diseases, cancers, and musculoskeletal conditions. The U.S. is home to several key players in medical imaging technology, and the growing number of hospitals, outpatient clinics, and diagnostic centers investing in advanced elastography systems is further driving market growth. The region is also supported by government initiatives and funding to enhance healthcare services, alongside strong reimbursement policies. The focus on early disease detection, particularly liver fibrosis and cancer, further fuels the demand for ultrasound elastography systems. Canada follows closely, with increasing awareness and adoption of these systems in both diagnostic and research applications.

Europe holds a substantial share of the Ultrasound Elastography System Market, with countries like Germany, France, the United Kingdom, and Italy leading the market. The European region has a well-established healthcare infrastructure, and the demand for elastography systems is driven by the increasing prevalence of liver diseases, cancers, and musculoskeletal disorders. Germany, known for its advanced healthcare system, is one of the largest markets for ultrasound elastography, supported by a high number of hospitals and diagnostic centers equipped with state-of-the-art imaging technologies. The United Kingdom and France are also significant contributors due to the growing emphasis on early diagnosis and non-invasive testing methods. Moreover, European regulatory bodies such as the European Medicines Agency (EMA) have facilitated the adoption of advanced imaging technologies, contributing to the growth of elastography systems. The region is also seeing increased investments in medical research, particularly in developing non-invasive diagnostic solutions for liver fibrosis, cancers, and other chronic diseases.

Asia-Pacific region is experiencing rapid growth in the Ultrasound Elastography System Market, driven by the expanding healthcare infrastructure, increasing awareness of early disease diagnosis, and rising healthcare investments in countries such as China, India, Japan, and South Korea. China is a key market, driven by its large population and rising healthcare demands, with a focus on chronic diseases such as liver disease, hepatitis, and cancer. The government’s initiatives to improve healthcare infrastructure, along with the rising healthcare expenditure, are key factors contributing to the growth of elastography systems in China. India is also emerging as a significant market, where increasing awareness, a growing patient population, and the expansion of diagnostic centers are driving demand. Japan and South Korea are adopting advanced imaging technologies rapidly, thanks to their advanced healthcare systems and emphasis on medical research and technology. The growing focus on non-invasive diagnostic techniques and early detection of liver fibrosis, cancer, and cardiovascular diseases further propels the market.

Latin America is seeing steady growth in the Ultrasound Elastography System Market, driven by increasing healthcare investments in countries like Brazil, Mexico, and Argentina. The growing prevalence of chronic liver diseases, particularly in Brazil, is leading to the increased adoption of elastography systems in diagnostic and research settings. Mexico is emerging as a hub for medical imaging technologies, with healthcare infrastructure improvements and increasing government spending on healthcare services. In Argentina, the rising focus on non-invasive diagnostic techniques, especially for liver diseases such as cirrhosis and fibrosis, is driving demand. However, economic challenges in some parts of the region and disparities in healthcare access may limit the widespread adoption of ultrasound elastography systems. Despite these challenges, the rising adoption of non-invasive diagnostic technologies and healthcare development is expected to propel the market in the long term.

Middle East and Africa region is poised for significant growth in the Ultrasound Elastography System Market, especially in countries like the United Arab Emirates (UAE), Saudi Arabia, South Africa, and Egypt. In the UAE and Saudi Arabia, healthcare investments are increasing rapidly, with a focus on modernizing healthcare infrastructure and adopting advanced diagnostic technologies. The demand for ultrasound elastography systems is driven by the growing prevalence of liver diseases, musculoskeletal disorders, and cancers. In South Africa, there is a rising adoption of non-invasive diagnostic technologies, particularly in hospitals and diagnostic centers. Egypt is similarly increasing its focus on improving healthcare and medical imaging technologies, driving the growth of elastography systems. However, some challenges in terms of limited healthcare infrastructure in certain regions of Africa may slow down market growth in Sub-Saharan Africa. Despite these challenges, the growing interest in modernizing healthcare systems and improving diagnostic capabilities in the MEA region will likely drive demand for ultrasound elastography systems?

Ultrasound Elastography System Market: Competitive Landscape

The report provides an in-depth analysis of companies operating in the ultrasound elastography system market, including their geographic presence, business strategies, product offerings, market share, and recent developments. This analysis helps to understand market competition.

Some of the major players in the global ultrasound elastography system market include:

• SAMSUNG
• CHISON
• ECHOSENS
• SIUI
• SonoScape Medical
• Shenzhen Mindray Bio-Medical Electronics
• Shenzhen Landwind Industry
• Supersonic Imagine
• Siemens Healthineers
• Toshiba America Medical Systems
• GE Healthcare
• BK Ultrasound
• Koninklijke Philips
• Hitachi Medical Systems
• Esaote

The global ultrasound elastography system market is segmented as follows:

By Technique

• Static Elastography
• Dynamic Elastography with Harmonic Stimuli
• Dynamic Elastography with Transient Stimuli

By Application

• Liver Disease
• Breast Lesion
• Prostate Cancer
• Thyroid
• Kidney
• Lymph Node
• Others

By End-User

• Hospitals
• Diagnostic Imaging Centers
• Radiology Centers

By Region

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • France
  • Germany
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• The Middle East and Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East Africa

Frequently Asked Questions